Zentek (TSE:ZEN)
TSXV:ZEN
Holding TSE:ZEN?
Track your performance easily

Zentek (ZEN) Stock Price & Analysis

45 Followers

ZEN Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

17.57%0.00%<0.01%82.43%
17.57% Insiders
<0.01% Other Institutional Investors
82.43% Public Companies and
Individual Investors

ZEN FAQ

What was Zentek’s price range in the past 12 months?
Zentek lowest stock price was C$1.26 and its highest was C$2.23 in the past 12 months.
    What is Zentek’s market cap?
    Currently, no data Available
    When is Zentek’s upcoming earnings report date?
    Zentek’s upcoming earnings report date is Aug 29, 2024 which is in 6 days.
      How were Zentek’s earnings last quarter?
      Zentek released its earnings results on Feb 23, 2024. The company reported -C$0.027 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.027.
        Is Zentek overvalued?
        According to Wall Street analysts Zentek’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Zentek pay dividends?
          Zentek does not currently pay dividends.
          What is Zentek’s EPS estimate?
          Zentek’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Zentek have?
          Zentek has 101,229,980 shares outstanding.
            What happened to Zentek’s price movement after its last earnings report?
            Zentek reported an EPS of -C$0.027 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.211%.
              Which hedge fund is a major shareholder of Zentek?
              Currently, no hedge funds are holding shares in TSE:ZEN
              ---

              Zentek Stock Smart Score

              Company Description

              Zentek

              Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?Zentek is?currently?focused on commercializing ZENGuard™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases.?The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Zentek
              Zynex
              Zymeworks
              Astrotech
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis